Advanced Therapy Medicinal Products (ATMPs)

‍ModaFlow™: Empowering the Next Generation of Therapeutics

ModaFlow™ is at the forefront of accelerating immunotherapeutics by revolutionizing antibody discovery. With advanced droplet microfluidics, our platform enables high-throughput screening of immune repertoires, allowing precise encapsulation and analysis of single B cells to rapidly identify potent antibodies. This breakthrough technology ensures a controlled microenvironment that mimics physiological conditions, driving innovation in immunotherapy for cancer, autoimmune disorders, and infectious diseases.

Beyond immunotherapeutics, ModaFlow™ extends its impact to a broad range of advanced therapeutic applications. Our platform is ideally suited for Advanced Therapy Medicinal Products (ATMPs), including:

• CAR-T Cells and Gene Therapies: Gentle processing preserves cell viability and functionality, critical for developing personalized treatments.
• Extracellular Vesicles (EVs): High-throughput analysis facilitates the selection and characterization of EVs for diagnostic and therapeutic purposes.
• Multi-Omics and Potency Assays: Integrated droplet microfluidics enables simultaneous analysis of cell-cell interactions, secretome responses, and other critical parameters.

Featuring a 5-color fluorescent detection system, high-throughput sorting, real-time visual monitoring, and gentle single-cell dispensing, ModaFlow™ integrates robust hardware and software modules into one streamlined bench-top instrument. This versatility not only maximizes screening throughput and efficiency but also supports seamless integration with traditional imaging workflows, ensuring comprehensive data integrity and accelerated R&D discovery.

With ModaFlow™, researchers gain an all-in-one solution that brings cutting-edge droplet microfluidic technology to the heart of therapeutic innovation, making it an indispensable tool for advancing immunotherapeutics and other transformative biomedical applications.

‍